Can the Hypertrophy of Contralateral Testis Predict the Absence of the Non-palpable Testis in the Boys Aged From 6months to 18months of Age ?
1 other identifier
observational
60
1 country
1
Brief Summary
The aim of this study is to verify whether the hypertrophy of contralateral testis may predict the absence of the non-palpable testis in the boys younger than 24months of age. According to the previous studies of other countries, the large size of the contralateral testis of the nonpalpable testis has positive correlation woth the weak viability of the affected testis. We are going to evaluate this hypothesis with prospective study. 3 groups are going to be enrolled into this study ; non-palpable testis group(Group1), palpable but not normally descended testis group(group2) and control group(group3). The size of testis will be measured with Ultrasound and the length, width and the height will be measured before surgery at outpatient department. For the group 1 \& 2, the viability of the affected testis will be evaluated and compared after surgery. In addition the comparison with normal control group is also going th be conducted.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jul 2014
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2014
CompletedFirst Submitted
Initial submission to the registry
July 27, 2014
CompletedFirst Posted
Study publicly available on registry
July 29, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2015
CompletedNovember 1, 2016
October 1, 2016
10 months
July 27, 2014
October 31, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Size of contralateral testis
The testicular size is measured 3-dimensionally with ultrasonography. The length, width and height will be measured and the volume of testis will be evaluated.
1 day of initial visit
Study Arms (3)
control
healthy children with normal bilateral testis
undescended palpable testis
patient whose affected testis is not descended to the normal position but palpable and exist intact in the upper area
non-paplpable testis
patient whose affected testis is not palpable during the physical examination
Eligibility Criteria
totally, 72 children : unpalpable testis : 24 children, palpable undescended testis : 24 children, normal control : 24 children
You may qualify if:
- neonates or Infants who visited the out-patient clinic with nonpalpable or undescended testis.(group 1, 2) aged from 6months to 18months
- neonates or Infants aged from 6months to 18months with normal testis (volunteers, Group3)
You may not qualify if:
- previous history of hormonal therapy.
- chromosomal abnormality
- previous history of abdomen or inguinal area surgery
- children diagnosed with epididymitis or orchitis
- twin baby
- infants with premature (\<37 weeks) birth history
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Severance Hospital, Yonsei University College of Medicine
Seoul, Seoul, 120-752, South Korea
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 27, 2014
First Posted
July 29, 2014
Study Start
July 1, 2014
Primary Completion
May 1, 2015
Study Completion
June 1, 2015
Last Updated
November 1, 2016
Record last verified: 2016-10